EUCTR2010-018862-22-DE进行中(未招募)不适用
Exploratory study to evaluate different MRI-contrast-agent-application-schemes using Gadovist to optimize contrast enhancement for longer lasting breast examination - Contrast agent application scheme
Kliniken Essen-Mitte0 个研究点目标入组 50 人开始时间: 2010年6月9日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) Adult patients, age 18 years and older
- •2) with recent diagnosis of breast cancer, histologically proven (within the last 6 weeks before inclusion)
- •3) referred to contrast-enhanced MRI of the breast for clinical reasons before surgery
- •4) willing and able to comply with and complete all study procedures
- •5) who provided written informed consent voluntarily and in person
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1) If female, being pregnant or in nursery (females of childbearing potential must have a negative urine pregnancy test at the day of MRI prior to administration of gadobutrol
- •2) Any contraindication to the MRI procedure (e.g., metal implants, phobia)
- •3) Any contraindication to gadolinium-containing MR contrast agents
- •4) History of severe allergic or anaphylactoid reaction to any allergen including drugs and contrast agents
- •5) Having received any contrast agent within 24 hours prior to the MRI examination planned in this study
- •6) Considered to be clinically unstable or risk of unpredictable clinical course during the study period (e.g., due to previous surgery, acute renal failure)
- •7) Severe cardiovascular disease (e.g., known long QT syndrome, acute myocardinal infraction [<14 days], unstable angina, congestive heart failure NYHA class IV) or acute stroke (<48 hours)
- •8) Severly or moderately impaired renal function (GFR calculated with MDRD formular 9) Scheduled or likely to require surgery and/ or biopsy before MRI or within 24 hours after study drug administration
- •10) Participating in another diagnostic clinical trial
- •11) Having previously entered this study
- •12) Patients with a heart rate > 100/ min (measured before the MRI examination)
- •13) Patients with a blood pressure > Systole/ Diastole 200/ 100 mmHg (measured before the MRI-examination)
研究者
相似试验
尚未招募
不适用
Prospective intrapatient Comparison of MRI-based risk models, intraoperative Cerenkov luminescence imaging and printed 3D-models to detect extracapsular extension in intermediate- and high-risk prostate cancerC61Malignant neoplasm of prostateDRKS00025059niversitätsklinikum Essen15
已完成
不适用
How does training in mindfulness meditation effect the brain structure and cognition?Meditation practiceISRCTN68095597Aarhus University (Denmark)60
尚未招募
不适用
A study of Magnetic Resonance Imaging(MRI) evaluation in knee joint pathologies.CTRI/2018/05/013938Department of Radiodiagnosis Government Medical College and Sir T HospitalBhavnagar
进行中(未招募)
不适用
Intra-individual, randomized comparison of the MRI contrast agents Gadovist 1.0 versus Dotarem when imaging the pelvis in patients with spondylarthritides, evaluated in a blinded readPolyarthritisMedDRA version: 9.1Level: LLTClassification code 10046107Term: Unspecified polyarthropathy or polyarthritis involving pelvic region and thighEUCTR2007-004222-24-DEDekan des FB Medizin der Johann-Wolfgang Goethe-Universität60
进行中(未招募)
不适用
Intra-individual, randomized comparison of the MRI contrast agents Gadovist® 1.0 versus Prohance® in patients with primary and secondary brain tumors, evaluated in a blinded readEUCTR2007-002888-27-DEKnappschaftskrankenhaus Bochum
